Breaks Categories: News

TuesdayMay 02, 2017 2:45 pm

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Launches Marijuana Accelerator Division

Diversified holding company Player’s Network, Inc. (OTCQB: PNTV) today announced the launch of a new division called Marijuana Accelerator following its acquisition of Marijuana Incubator. The launch of Marijuana Accelerator is part of PNTV’s overall strategy to gain market share by developing a national footprint in the legal medical marijuana industry. “The marijuana industry is lacking much-needed accelerator and incubator-style mentoring organizations, and we are pleased to present our unique solution to meet this need,” Brett H. Pojunis, member of PNTV’s board of directors, stated in today’s news release. “There is a lot of excitement in this industry. It reminds…

Continue Reading

TuesdayApr 25, 2017 1:28 pm

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Announces Engagement of CannabisNewsWire

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its engagement of CannabisNewsWire (CNW) for corporate communications solutions. CNW is a multifaceted financial news and publishing company working to help public and private organizations find their voice and build market visibility by leveraging a rapidly expanding distribution network of more than 5,000 key syndication outlets. “We have an exciting pipeline of phytocannabinoid-based treatments based on our formulation for pain,” Ram Mukunda, CEO of IGC, stated in this morning’s news release. “As we move toward pre clinical and…

Continue Reading

MondayApr 10, 2017 10:01 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Submits International Patent Applications for IGC-501

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has filed patent applications for IGC-501 in Canada, Israel and Europe in support of its ongoing cannabis-based combination therapy development initiatives. “We continue to strengthen our IP position in cannabis-based combination therapies and have progressed to include global patent filings,” Ram Mukunda, CEO of IGC, stated in the news release. “IGC is committed to addressing high potential international markets as a first mover in this emerging segment of cannabis-based combination therapy pharmaceuticals.” IGC-501 is being developed…

Continue Reading

ThursdayApr 06, 2017 12:26 pm

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) CEO Releases Letter to Shareholders

Diversified holding company Player's Network, Inc. (OTCQB: PNTV) today released a shareholder letter from CEO Mark Bradley discussing several of the company’s recent achievements, as well as its corporate outlook for the remainder of 2017. Among PNTV’s first quarter highlights, the company completed an uplisting to the OTCQB® Venture Market and paid down the majority of its outstanding debt. Through its Green Leaf Farms Holdings ("GLFH") subsidiary, of which PNTV owns an 86 percent stake, the company also received a Certificate of Occupancy from the City of North Las Vegas for the first phase of a planned 27,000-square-foot facility that…

Continue Reading

ThursdayApr 06, 2017 11:03 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Broadens its Horizon with Pipeline of Cannabis-Based Therapies

Since its inception in 2005, India Globalization Capital (NYSE: IGC) has transitioned from a mining company to a developer of cannabis-based therapies. The company is unique in that it uses cannabis-based extracts in combination with other medications to reduce side effects and increase bioavailability and absorption. “The company now has a pipeline of patent pending cannabinoid-based drugs targeting large market maladies, which includes therapeutics for neuropathic pain, human and animal seizures, refractory epilepsy and eating disorders. Several of these therapeutic drugs are scheduled for pre-clinical trials this year. The company is transitioning fast from building research teams and developing a…

Continue Reading

WednesdayApr 05, 2017 11:14 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Attending ‘Invest 2017’ Exhibition

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced plans to attend the ‘Invest 2017’ exhibition, which is set to take place on April 7-8 in Stuttgart, Germany. Noted as the leading trade fair and congress for finance and investment in Germany, Invest 2017 is expected to provide CIIX with an opportunity to introduce its media and nutritional hemp companies to a crowd of German investors. “I am delighted that CIIX is invited to attend Invest 2017 as an exhibitor,” Warren Wang, founder and CEO of CIIX, stated in this morning’s news release. “This exhibition provides CIIX a valuable…

Continue Reading

WednesdayApr 05, 2017 10:11 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Announces Sale of Brilliant Hallmark Stake

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the sale of its investment interest in Brilliant Hallmark for a consideration of four million shares of IGC. The shares, which were previously issued to Brilliant Hallmark on August 4, 2016, will be returned and retired, while the Brilliant Hallmark investment will be removed from the company's balance sheet with an associated reduction of roughly $1.88 million. Per this morning’s update, IGC does not expect to record a gain or loss from this transaction. “This strategic move is…

Continue Reading

TuesdayApr 04, 2017 3:50 pm

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (IMLFF) Takes Aim at Rare Skin Diseases with INM-750

Epidermolysis bullosa (EBS) is a group of rare inherited skin diseases that unfortunately have no currently approved or known cure or treatment. InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has developed INM-750 as the first therapy to specifically treat EBS. “Earlier this month, InMed filed an international Patent Cooperation Treaty application for intellectual and commercial protection of INM-750 and a cannabinoid-based therapy for EBS. This marks a significant milestone for the company, serving as validation for its efforts to develop new therapies based on cannabinoids and its unique approach to drug development. The company is using a proprietary bioinformatics assessment tool to…

Continue Reading

ThursdayMar 30, 2017 11:13 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Invests in Breakwater MB, LLC

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company formed by CIIX board member and former CFO Paul Dickman. CIIX’s initial investment into Breakwater MB will total $250,000, with the company maintaining an option to make additional investments at its own election. Per the news release, Breakwater MB intends to use the invested capital primarily to cover the costs of becoming a publicly traded company. CIIX management expects that this strategy will provide significant investment appreciate and opportunity for liquidity. “With the gradual opening up of the…

Continue Reading

ThursdayMar 23, 2017 9:38 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Audio Interview with CannabisNewsWire

Multifaceted financial news and publishing company CannabisNewsWire this morning announced the online availability of a new audio interview with India Globalization Capital, Inc. (NYSE MKT: IGC) CEO Ram Mukunda. In the interview, Mukunda discusses IGC’s operations and targeted market, as well as leading formulations currently in the company’s development pipeline. “This is a very exciting time for us, an exciting opportunity,” Mukunda noted in the interview. “We believe that we have first-mover advantage in combination therapy, as very few companies are actually working on cannabis-based pharmaceuticals and within that space we believe that we are the only ones working on…

Continue Reading